miR-299a-5p is a mediator of fibrosis in diabetic kidney disease by regulating follistatin and cripto-1. [PDF]
Nmecha IK +7 more
europepmc +1 more source
Salvage Use of Sotatercept for Potts Shunt in Refractory Pulmonary Hypertension. [PDF]
Xu Z +8 more
europepmc +1 more source
Elevated Activin-A serum levels in patients with acute peripartum cardiomyopathy and during left ventricular recovery. [PDF]
Gausepohl T +8 more
europepmc +1 more source
Novel agents and evolving strategies for anemia management in lower-risk myelodysplastic syndromes. [PDF]
Hong J.
europepmc +1 more source
Sotatercept as an Add-On to Background Therapy in Idiopathic Pulmonary Arterial Hypertension: Insights from a Real-World Cohort. [PDF]
Filippatos C +7 more
europepmc +1 more source
The role of anti-Müllerian hormone as a therapeutic agent to preserve the ovarian follicle pool during chemotherapy. [PDF]
Peregrin-Alvarez I +7 more
europepmc +1 more source
The Evolving Landscape of Pulmonary Vascular Disease: Current Advances and Future Directions in Pulmonary Hypertension and Pulmonary Embolism. [PDF]
Cacia MA, Imbalzano E, Vatrano M.
europepmc +1 more source
Secretion of placental peptide hormones: functions and trafficking. [PDF]
Ahmadi SM, Perez ML, Guardia CM.
europepmc +1 more source
Association Between Follistatin and PAI-1 Levels in MASLD Subjects Undergoing a Plant-Based Dietary Intervention. [PDF]
Cerabino N +11 more
europepmc +1 more source

